Clinical progress note: Indications for and management of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in hospitalized patients.
Publication
, Journal Article
Sata, SS; Spratt, SE; Edmonston, DL; Pagidipati, N
Published in: J Hosp Med
May 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Hosp Med
DOI
EISSN
1553-5606
Publication Date
May 2022
Volume
17
Issue
5
Start / End Page
360 / 363
Location
United States
Related Subject Headings
- Sodium
- Hypoglycemic Agents
- Humans
- Glucose
- General & Internal Medicine
- Diabetes Mellitus, Type 2
- 4205 Nursing
- 4203 Health services and systems
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sata, S. S., Spratt, S. E., Edmonston, D. L., & Pagidipati, N. (2022). Clinical progress note: Indications for and management of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in hospitalized patients. J Hosp Med, 17(5), 360–363. https://doi.org/10.1002/jhm.12798
Sata, Suchita Shah, Susan E. Spratt, Daniel L. Edmonston, and Neha Pagidipati. “Clinical progress note: Indications for and management of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in hospitalized patients.” J Hosp Med 17, no. 5 (May 2022): 360–63. https://doi.org/10.1002/jhm.12798.
Sata SS, Spratt SE, Edmonston DL, Pagidipati N. Clinical progress note: Indications for and management of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in hospitalized patients. J Hosp Med. 2022 May;17(5):360–3.
Sata, Suchita Shah, et al. “Clinical progress note: Indications for and management of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in hospitalized patients.” J Hosp Med, vol. 17, no. 5, May 2022, pp. 360–63. Pubmed, doi:10.1002/jhm.12798.
Sata SS, Spratt SE, Edmonston DL, Pagidipati N. Clinical progress note: Indications for and management of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in hospitalized patients. J Hosp Med. 2022 May;17(5):360–363.
Published In
J Hosp Med
DOI
EISSN
1553-5606
Publication Date
May 2022
Volume
17
Issue
5
Start / End Page
360 / 363
Location
United States
Related Subject Headings
- Sodium
- Hypoglycemic Agents
- Humans
- Glucose
- General & Internal Medicine
- Diabetes Mellitus, Type 2
- 4205 Nursing
- 4203 Health services and systems
- 1103 Clinical Sciences